In this study, the hybrid-based FS pipeline screened an optimal subset that includes three gene biomarkers, namely MAPK1, APOBEC3B, and ENAH, for earlier detection of primary breast tumors. The gene discussed is MAPK1; the disease is breast neoplasm.